News & Updates

In patients with focal epilepsy, seizure frequency at baseline and the number of previous antiseizure medications (ASMs) used can predict sustained reduction in seizure frequency with adjunctive brivaracetam, according to data from the BRIVAFIRST study.

Findings from the ACHIEVE* study suggest that older adults who are at increased risk for cognitive decline and dementia and who have hearing loss may benefit the most from hearing intervention within 3 years.

In the phase III TRAILBLAZER-ALZ 2 study, donanemab significantly slowed clinical progression in individuals with early symptomatic Alzheimer’s disease* (AD) with amyloid and tau pathologies, demonstrating an important replication of the phase II findings.

Delivering electrical stimulation over the cerebellum appears to improve gait disturbances in patients with Parkinson’s disease (PD) and help them walk better, as reported in a study from Japan.

Eating nuts on a regular basis provides neuroprotective benefits to older adults who are overweight or obese, have metabolic syndrome, and are predisposed to memory loss or confusion, results of a cohort study have shown.